Series C+ · 2026-10-16 · Healthcare
Microbiotica raises $45.4M
62
AI Score
Amount
$45.4M
Round
Series C+
Lead
British Business Bank
HQ
GB
Why it matters: Microbiotica's Series C first close shows how genomics and machine learning are moving microbiome drug candidates into Phase 2 trials.
British clinical-stage biopharma company Microbiotica announced the first close of a €42 million Series C round led by British Business Bank.
- Participants:
- Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, Seventure Partners
- Source:
- EU-Startups ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Microbiotica
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
More deals with British Business Bank
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing